liver
Professor Maria Rescigno explores the critical role of the gut microbiota in maintaining intestinal barrier integrity and its implications for health.
New microbiome based therapy demonstrates safety and potential benefits for liver cirrhosis and mental health.
The findings of a recent study suggest that combining dietary fiber with B. acidifaciens can be a therapeutic strategy for alcoholic liver disease.
Satish Chandran, President and Chief Executive Officer at Prodigy Biotech, Inc., details the company's program aimed at treating alcoholic liver disease, spotlighting Enterococcus faecalis as the primary antagonist.
The findings suggest that microbial metabolites can help to predict who is at increased risk of infection after liver transplant. The results may also help to inform microbiota-targeted therapies.
The findings of a recent study suggest that modulating the gut microbiota in people with liver cancer can improve their health outcomes after surgery.
The findings of a recent study suggest that resistant-starch supplements can alter the gut microbiota in ways that alleviate NAFLD.
Scientists identified a bacterium, Bacteroides xylanisolvens, that reduced gut nicotine concentrations in mice exposed to nicotine as well as the severity of NAFLD.
The findings of a new research suggest that, in some people, microbial ethanol can contribute to the development of NAFLD.
Faecal microbiota transplant appears to effectively improve both clinical parameters and bacterial balance in the liver, especially in thin individuals.
